相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Age and sex associate with outcome in older AML and high risk MDS patients treated with 10-day decitabine
Jacobien Hilberink et al.
BLOOD CANCER JOURNAL (2023)
Core-binding factor acute myeloid leukemia: long-term outcome of 70 patients uniformly treated with 7+3
K. H. Begna et al.
BLOOD CANCER JOURNAL (2022)
Integrative analysis identifies an older female-linked AML patient group with better risk in ECOG-ACRIN Cancer Research Group's clinical trial E3999
Franck Rapaport et al.
BLOOD CANCER JOURNAL (2022)
Comorbidities and malignancies negatively affect survival in myelodysplastic syndromes: a population-based study
Johanne Rozema et al.
BLOOD ADVANCES (2021)
Prognostic effect of gender on outcome of treatment for adults with acute myeloid leukaemia
Peter H. Wiernik et al.
BRITISH JOURNAL OF HAEMATOLOGY (2021)
Epidemiology of myelodysplastic syndromes: Why characterizing the beast is a prerequisite to taming it
Amer M. Zeidan et al.
BLOOD REVIEWS (2019)
Epidemiology of acute myeloid leukemia: Recent progress and enduring challenges
Rory M. Shallis et al.
BLOOD REVIEWS (2019)
Effects of Education and Income on Treatment and Outcome in Patients With Acute Myeloid Leukemia in a Tax-Supported Health Care System: A National Population-Based Cohort Study
Lene Sofie Granfeldt Ostgard et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Epidemiological patterns of leukaemia in 184 countries: a population-based study
Adalberto Miranda-Filho et al.
Lancet Haematology (2017)
Treatment, trial participation and survival in adult acute myeloid leukemia: a population-based study in the Netherlands, 1989-2012
A. G. Dinmohamed et al.
LEUKEMIA (2016)
Trends in incidence, primary treatment and survival in chronic myelomonocytic leukaemia: a population-based study of 1359 patients diagnosed in the Netherlands from 1989 to 2012
Avinash G. Dinmohamed et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Survival variations by country and age for lymphoid and myeloid malignancies in Europe 2000-2007: Results of EUROCARE-5 population-based study
Roberta De Angelis et al.
EUROPEAN JOURNAL OF CANCER (2015)
The use of medical claims to assess incidence, diagnostic procedures and initial treatment of myelodysplastic syndromes and chronic myelomonocytic leukemia in the Netherlands
Avinash G. Dinmohamed et al.
LEUKEMIA RESEARCH (2015)
Differences in incidence and trends of haematological malignancies in Japan and the United States
Dai Chihara et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Trends in incidence, initial treatment and survival of myelodysplastic syndromes: A population-based study of 5144 patients diagnosed in the Netherlands from 2001 to 2010
Avinash G. Dinmohamed et al.
EUROPEAN JOURNAL OF CANCER (2014)
Tamibarotene As Maintenance Therapy for Acute Promyelocytic Leukemia: Results From a Randomized Controlled Trial
Katsuji Shinagawa et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Incidence of Myelodysplastic Syndrome in Japan
Dai Chihara et al.
JOURNAL OF EPIDEMIOLOGY (2014)
Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study
Milena Sant et al.
LANCET ONCOLOGY (2014)
Investigation of the freely available easy-to-use software 'EZR' for medical statistics
Y. Kanda
BONE MARROW TRANSPLANTATION (2013)
ERYTHROPOIETIN LEVEL IN SICKLE CELL DISEASE PATIENTS NOT IN CRISIS
D. Pulte et al.
HAEMATOLOGICA (2013)
Survival of European patients diagnosed with myeloid malignancies: a HAEMACARE study
Marc Maynadie et al.
HAEMATOLOGICA (2013)
Recent trends in survival of adult patients with acute leukemia: overall improvements, but persistent and partly increasing disparity in survival of patients from minority groups
Dianne Pulte et al.
HAEMATOLOGICA (2013)
Randomized comparison of fixed-schedule versus response-oriented individualized induction therapy and use of ubenimex during and after consolidation therapy for elderly patients with acute myeloid leukemia: the JALSG GML200 Study
Atsushi Wakita et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2012)
Randomized study of induction therapy comparing standard-dose idarubicin with high-dose daunorubicin in adult patients with previously untreated acute myeloid leukemia: the JALSG AML201 Study
Shigeki Ohtake et al.
BLOOD (2011)
Incidence of the myelodysplastic syndromes using a novel claims-based algorithm: high number of uncaptured cases by cancer registries
Christopher R. Cogle et al.
BLOOD (2011)
Twenty-five years of epidemiological recording on myeloid malignancies: data from the specialized registry of hematologic malignancies of Cote d'Or (Burgundy, France)
Marc Maynadie et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Incidence and prevalence of myelodysplastic syndromes: Data from the Dusseldorf MDS-registry
Judith Neukirchen et al.
LEUKEMIA RESEARCH (2011)
Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project
Milena Sant et al.
BLOOD (2010)
Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials
David Grimwade et al.
BLOOD (2010)
Incidence and Clinical Complications of Myelodysplastic Syndromes Among United States Medicare Beneficiaries
Stuart L. Goldberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry
Gunnar Juliusson et al.
BLOOD (2009)
Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs
Dana E. Rollison et al.
BLOOD (2008)
A randomized study with or without intensified maintenance chemotherapy in patients with acute promyelocytic leukemia who have become negative for PML-RARα transcript after consolidation therapy:: The Japan Adult Leukemia Study Group (JALSG) APL97 study
Norio Asou et al.
BLOOD (2007)
A randomized, postremission comparison of four courses of standard-dose consolidation therapy without maintenance therapy versus three courses of standard-dose consolidation with maintenance therapy in adults with acute myeloid leukemia - The Japan adult leukemia study group AML97 study
S Miyawaki et al.
CANCER (2005)
The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial
D Grimwade et al.
BLOOD (2001)
Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study
ML Slovak et al.
BLOOD (2000)
分享论文
